Healthcare & Life Sciences
Healthcare & Life Sciences
From FDA-cleared AI products to clinical data platforms, Quantiva builds technology that meets the highest regulatory standards and ships fast.
Our Approach
Healthcare technology demands precision in both engineering and compliance. Quantiva builds production-grade systems that satisfy FDA design controls, HIPAA requirements, and clinical validation standards without the typical 18-month timeline.
We've taken AI products from research prototype to FDA 510(k) clearance, built clinical data platforms processing millions of patient records, and delivered medical imaging systems used in radiation oncology treatment planning. Our team understands the regulatory path because we've walked it. Not as consultants, but as the engineers architecting HIPAA-compliant cloud infrastructure, building integrations with hospital systems in Java and .NET, and signing the design history files.
We work across regulated software as a medical device (SaMD), clinical data engineering and AI/ML pipelines, and digital health platforms connecting patients to providers. The approach is always the same: ship early, validate continuously, and treat compliance as a design constraint, backed by infrastructure-as-code practices that make every environment reproducible and audit-ready from development through production.
Health systems commercializing research, MedTech startups building a first FDA submission, life sciences companies modernizing clinical workflows: we move faster than most people think is possible in healthcare.
Results
Related Case Studies
Insights
Related Articles
October 27, 2025
We're Building an AI Early Warning System for Viral Outbreaks
CDC reports arrive too late to stop outbreaks. A pharma company asked us to process millions of daily data points from hospitals, labs, and public sources to predict where outbreaks will hit next.
Read more →
April 24, 2025
From Research Prototype to FDA-Cleared AI: What It Actually Takes
Penn Medicine had an AI model that could contour organs for radiation therapy in minutes instead of hours. Turning that into an FDA-cleared commercial product is a different problem entirely. Here's how we did it.
Read more →
October 11, 2024
What We Learned at VivaTech About Medtech, Digital Twins, and Entering the US Market
We went to VivaTech in Paris to meet European startups trying to break into the US. The medtech companies were the most interesting. Here's what stood out and where we see opportunity.
Read more →